In vivo Sealing of Fetoscopy-Induced Fetal Membrane Defects by Mussel Glue

Fetal Diagn Ther. 2022;49(11-12):518-527. doi: 10.1159/000528473. Epub 2023 Jan 12.

Abstract

Introduction: The benefits of fetal surgery are impaired by the high incidence of iatrogenic preterm prelabor rupture of the fetal membranes (iPPROM), for which chorioamniotic separation has been suggested as a potential initiator. Despite the urgent need to prevent iPPROM by sealing the fetoscopic puncture site after intervention, no approach has been clinically translated.

Methods: A mussel-inspired biomimetic glue was tested in an ovine fetal membrane (FM) defect model. The gelation time of mussel glue (MG) was first optimized to make it technically compatible with fetal surgery. Then, the biomaterial was loaded in polytetrafluoroethylene-coated nitinol umbrella-shaped receptors and applied on ovine FM defects (N = 10) created with a 10 French trocar. Its sealing performance and tissue response were analyzed 10 days after implantation by amniotic fluid (AF) leakage and histological methods.

Results: All ewes and fetuses recovered well after the surgery, and 100% ewe survival and 91% fetal survival were observed at explantation. All implants were tight at explantation, and no AF leakage was observed in any of them. Histological analysis revealed a mild tissue response to the implanted glue.

Conclusion: MG showed promising properties for the sealing of FM defects and thereby the prevention of preterm birth. Studies to analyze the long-term tissue response to the sealant should be performed.

Keywords: Fetal membranes; Fetoscopy; Iatrogenic preterm prelabor rupture of the fetal membranes; In vivo sealing; Mussel glue.

MeSH terms

  • Animals
  • Extraembryonic Membranes / pathology
  • Female
  • Fetal Membranes, Premature Rupture* / etiology
  • Fetoscopy / adverse effects
  • Fetus / pathology
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Premature Birth*
  • Sheep

Grants and funding

This research was supported by Swiss National Science Foundation grant 31003A_141051/2, the Innosuisse grant 55482.1 IP-LS, and the National Institutes of Health (USA) grant R01 EB022031.